Skip to main content
. 2022 May 17;27(9):e748–e754. doi: 10.1093/oncolo/oyac092

Table 2.

31P spectroscopy data for rest, low intensity (40% peak power), high intensity (80% peak power) and peak exercise, and PCr recovery.

Spectroscopy variable Control (n = 16) Patients (n = 34)
Pre-chemotherapy Mid-chemotherapy End-chemotherapy One year
Pi:PCr resting 0.10 (0.02) 0.11 (0.02) 0.12 (0.03)a 0.12 (0.02)a 0.12 (0.02)a
Pi:PCr 40% intensity 0.31 (0.08) 0.29 (0.07) 0.34 (0.08)a 0.32 (0.07)a 0.32 (0.06)ab
Pi:PCr 80% intensity 0.61 (0.17) 0.58 (0.22) 0.62 (0.19)a 0.56 (0.17) 0.56 (0.22)b
Pi:PCr peak exercise 0.84 (0.23) 0.78 (0.29) 0.84 (0.26) 0.74 (0.22) 0.72 (0.28)
pH resting 7.09 (0.11) 7.07 (0.05) 7.09 (0.07) 7.07 (0.04) 7.08 (0.04)
pH 40% intensity 7.07 (0.08) 7.08 (0.06) 7.06 (0.07) 7.09 (0.04) 7.11 (0.06)
pH 80% intensity 6.75 (0.3) 6.86 (0.19) 6.79 (0.22)a 6.84 (0.20) 6.90 (0.21)b
pH peak exercise 6.62 (0.28) 6.73 (0.21) 6.67 (0.22) 6.73 (0.29) 6.77 (0.24)
PCr recovery time constant (s) 33 (9) 37 (13) 40 (17) 38 (11) 33 (10)b

Different from pre-chemotherapy (P ≤ .05).

Different from mid-chemotherapy (P ≤ .05).